Semaglutide 0.5mg ODT — 90ct

What is Semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist originally developed for type 2 diabetes management. It belongs to a class of medications that mimic a hormone your body naturally produces after eating. Today it is among the most studied and prescribed peptides for weight management in clinical practice.

How It Works

Semaglutide binds to GLP-1 receptors throughout the body — in the brain, pancreas, and digestive tract. In the brain, it signals satiety, reducing appetite and cravings. In the digestive tract, it slows gastric emptying, so you feel full longer after eating. In the pancreas, it supports insulin regulation in response to food intake. The result is a significant reduction in overall caloric intake without the willpower struggle.

Key Benefits

Research consistently shows semaglutide supports meaningful reductions in body weight over time. Clinical trials have demonstrated average weight loss of 10–15% of body weight in participants using therapeutic doses under medical supervision. Beyond weight, studies suggest improvements in blood sugar regulation, cardiovascular risk markers, and metabolic health. It is available both as a weekly subcutaneous injectable and as an orally disintegrating tablet (ODT) for patients who prefer a needle-free option.

What to Expect

Most patients begin with a low starter dose to allow the body to adjust, then progress through gradual titration under physician guidance. Appetite changes are typically noticed within the first few weeks. Steady weight loss generally follows over a 3–6 month period. Mild gastrointestinal effects such as nausea are common early on and usually resolve as the body adapts.

Quality & Sourcing

Every semaglutide formulation from Greenstone Peptides is compounded in the USA by licensed pharmacy partners under USP 797 sterile standards. Each batch is third-party tested for potency, sterility, and endotoxin.